We found three small trials (total 50 participants) of relaxation therapy. They were of poor methodological quality and a meta-analysis was therefore not undertaken. No study found a significant effect of relaxation therapy on seizure frequency.
Two trials found cognitive behavioural therapy (CBT) to be effective in reducing depression among people with epilepsy and a depressed affect, whilst another did not. Two trials of CBT found improvements in QOL scores. One trial of group cognitive therapy found no significant effect on seizure frequency while another trial found a statistically significant reduction in seizure frequency as well as seizure index (product of seizure frequency and seizure duration in seconds) among participants treated with CBT.
One small trial compared CBT with yoga and found similar rates of seizure freedom and 50% responder rates at the end of one year. Compared to pretest scores, the CBT group showed an improvement in the World Health Organization quality of life instrument, short version (WHO QOL-BREF) (P ≤ 0.01) while the yoga group had an improvement in their QOL according to the satisfaction with life scale (SWLS) (P ≤ 0.05).
Two trials of combined relaxation and behaviour therapy, one of electroencephalographic (EEG) bio-feedback and four of educational interventions did not provide sufficient information to assess their effects on seizure frequency.
One small study of galvanic skin response biofeedback reported significant reduction in seizure frequency.
Combined use of relaxation and behaviour modification was found beneficial for anxiety and adjustment in one study. In one study EEG bio-feedback was found to improve cognitive and motor functions in individuals with the greatest seizure reduction. Educational interventions were found to be beneficial in improving knowledge and understanding of epilepsy, coping with epilepsy, compliance to medication and social competencies.
Two trials investigated the effects of a self management program on QOL measures. One found no significant differences in overall QOL except for an improvement in the QOL in persons with epilepsy (QOLIE-89) role limitations - emotional score. The other study found no significant benefits in any of the outcomes studied except for more positive attitudes about the outcomes associated with taking medications.